Epocrates Re-Files for IPO

Epocrates Inc., a San Mateo, Calif.-based provider of clinical information and support tools to healthcare professionals, has filed for a $75 million IPO. It originally filed for a $75 million IPO in April 2008, but withdrew later that year, telling the SEC that its offering would have been “discretionary financing.”

The company plans to trade on the Nasdaq under ticker symbol EPOC, with J.P. Morgan and Piper Jaffray serving as co-lead underwriters. Citi had been listed as sole underwriter on the previous S-1, but is not mentioned in the latest filing.

The company has raised over $86 million in VC funding, from firms like The Sprout Group (17.2% stake), Goldman Sachs (16.2%), InterWest Partners (12.8%), Draper Fisher Jurvetson (10.5%), Three Arch Partners (10.4%) and Bay City Capital (7.4%). www.epocrates.com

Related Posts

Leave a Reply

PEHUB Community

Join the 12501 members of peHUB to make connections, share your opinion, and follow your favorite authors.

Join the Community

Look Who’s Tweeting

Psst! Got any hot tips?

  • This field is for validation purposes and should be left unchanged.

PE HUB News Briefs

RSS Feed Widget

Marketplace

VCJ Headlines (subscribers only)

RSS Feed Widget

Buyouts Headlines (subscribers only)

RSS Feed Widget

Reuters VC and PE feed

RSS Feed Widget